93 related articles for article (PubMed ID: 23968902)
1. Risk of emergent bradycardia associated with the use of carvedilol and metoprolol in routine clinical practice.
Shin J; Pletcher MJ
Am J Med; 2013 Sep; 126(9):805-810.e5. PubMed ID: 23968902
[TBL] [Abstract][Full Text] [Related]
2. Risk of emergent bradycardia associated with initiation of immediate- or slow-release metoprolol.
Shin J; Gonzales M; Pletcher MJ
Pharmacotherapy; 2013 Dec; 33(12):1353-61. PubMed ID: 23813768
[TBL] [Abstract][Full Text] [Related]
3. Effects of metoprolol and carvedilol on pre-existing and new onset diabetes in patients with chronic heart failure: data from the Carvedilol Or Metoprolol European Trial (COMET).
Torp-Pedersen C; Metra M; Charlesworth A; Spark P; Lukas MA; Poole-Wilson PA; Swedberg K; Cleland JG; Di Lenarda A; Remme WJ; Scherhag A;
Heart; 2007 Aug; 93(8):968-73. PubMed ID: 17237130
[TBL] [Abstract][Full Text] [Related]
4. Comparative effectiveness of beta-adrenergic antagonists (atenolol, metoprolol tartrate, carvedilol) on the risk of rehospitalization in adults with heart failure.
Go AS; Yang J; Gurwitz JH; Hsu J; Lane K; Platt R
Am J Cardiol; 2007 Aug; 100(4):690-6. PubMed ID: 17697830
[TBL] [Abstract][Full Text] [Related]
5. Death and hospitalization in heart failure patients receiving carvedilol vs. metoprolol tartrate.
Delea TE; Stanford R; Hagiwara M; Edelsberg JS; Oster G
Int J Cardiol; 2005 Mar; 99(1):117-24. PubMed ID: 15721509
[TBL] [Abstract][Full Text] [Related]
6. Effect of metoprolol versus carvedilol on outcomes in MADIT-CRT (multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy).
Ruwald MH; Ruwald AC; Jons C; Alexis J; McNitt S; Zareba W; Moss AJ
J Am Coll Cardiol; 2013 Apr; 61(14):1518-26. PubMed ID: 23500269
[TBL] [Abstract][Full Text] [Related]
7. Persistence with nebivolol in the treatment of hypertension: a retrospective claims analysis.
Signorovitch JE; Samuelson TM; Ramakrishnan K; Marynchenko M; Wu EQ; Blum SI; Ramasamy A; Chen S
Curr Med Res Opin; 2012 Apr; 28(4):591-9. PubMed ID: 22352883
[TBL] [Abstract][Full Text] [Related]
8. Carvedilol versus controlled-release metoprolol for elderly veterans with heart failure.
Rector TS; Anand IS; Nelson DB; Ensrud KE
J Am Geriatr Soc; 2008 Jun; 56(6):1021-7. PubMed ID: 18384583
[TBL] [Abstract][Full Text] [Related]
9. Effects of carvedilol or metoprolol on PAI-1, tPA-mass concentration or Von Willebrand factor in chronic heart failure--a COMET substudy.
Boman K; Jansson JH; Nilsson T; Swedberg K; Cleland JG; Poole-Wilson P
Thromb Res; 2010 Feb; 125(2):e46-50. PubMed ID: 19762071
[TBL] [Abstract][Full Text] [Related]
10. Carvedilol or sustained-release metoprolol for congestive heart failure: a comparative effectiveness analysis.
Shore S; Aggarwal V; Zolty R
J Card Fail; 2012 Dec; 18(12):919-24. PubMed ID: 23207080
[TBL] [Abstract][Full Text] [Related]
11. Comparison of new-onset post-operative atrial fibrillation between patients receiving carvedilol and metoprolol after off-pump coronary artery bypass graft surgery.
Stone KH; Reynolds K; Davis S; Van Tassell BW; Gibson CM
Gen Thorac Cardiovasc Surg; 2023 May; 71(5):299-305. PubMed ID: 36180608
[TBL] [Abstract][Full Text] [Related]
12. Risk of new-onset diabetes mellitus associated with beta-blocker treatment for hypertension.
Fonseca V; Sharma PP; Shah M; Deedwania P
Curr Med Res Opin; 2011 Apr; 27(4):799-807. PubMed ID: 21306286
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the efficacy of metoprolol and carvedilol for preventing atrial fibrillation after coronary bypass surgery.
Acikel S; Bozbas H; Gultekin B; Aydinalp A; Saritas B; Bal U; Yildirir A; Muderrisoglu H; Sezgin A; Ozin B
Int J Cardiol; 2008 May; 126(1):108-13. PubMed ID: 17499863
[TBL] [Abstract][Full Text] [Related]
14. Comparison of carvedilol and metoprolol on serum lipid concentration in diabetic hypertensive patients.
Bell DS; Bakris GL; McGill JB
Diabetes Obes Metab; 2009 Mar; 11(3):234-8. PubMed ID: 18564334
[TBL] [Abstract][Full Text] [Related]
15. Effects of metoprolol and carvedilol on cause-specific mortality and morbidity in patients with chronic heart failure--COMET.
Torp-Pedersen C; Poole-Wilson PA; Swedberg K; Cleland JG; Di Lenarda A; Hanrath P; Komajda M; Lutiger B; Metra M; Remme WJ; Scherhag A; Skene A;
Am Heart J; 2005 Feb; 149(2):370-6. PubMed ID: 15846279
[TBL] [Abstract][Full Text] [Related]
16. [A randomized comparison of carvedilol and metoprolol in patients with chronic heart failure. The Carvedilol Or Metoprolol European Trial (COMET) ].
Torp-Pedersen CT;
Ugeskr Laeger; 2004 Aug; 166(32):2671-4. PubMed ID: 15347171
[No Abstract] [Full Text] [Related]
17. Comparative effects of carvedilol and metoprolol on regional vascular responses to adrenergic stimuli in normal subjects and patients with chronic heart failure.
Hryniewicz K; Androne AS; Hudaihed A; Katz SD
Circulation; 2003 Aug; 108(8):971-6. PubMed ID: 12912816
[TBL] [Abstract][Full Text] [Related]
18. Differential associations of beta-blockers with hemorrhagic events for chronic heart failure patients on warfarin.
Berlowitz DR; Miller DR; Oliveria SA; Cunningham F; Gomez-Caminero A; Rothendler JA
Pharmacoepidemiol Drug Saf; 2006 Nov; 15(11):799-807. PubMed ID: 16892457
[TBL] [Abstract][Full Text] [Related]
19. A comparison of the effects of carvedilol and metoprolol on well-being, morbidity, and mortality (the "patient journey") in patients with heart failure: a report from the Carvedilol Or Metoprolol European Trial (COMET).
Cleland JG; Charlesworth A; Lubsen J; Swedberg K; Remme WJ; Erhardt L; Di Lenarda A; Komajda M; Metra M; Torp-Pedersen C; Poole-Wilson PA;
J Am Coll Cardiol; 2006 Apr; 47(8):1603-11. PubMed ID: 16630997
[TBL] [Abstract][Full Text] [Related]
20. Beta-receptor selectivity of carvedilol and metoprolol succinate in patients with heart failure (SELECT trial): a randomized dose-ranging trial.
Zebrack JS; Munger M; Macgregor J; Lombardi WL; Stoddard GP; Gilbert EM
Pharmacotherapy; 2009 Aug; 29(8):883-90. PubMed ID: 19637941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
